m-Chloroperbenzoic acid → HCID 54588461, compound
Reaction equation
[C:1]1([C:7]2[S:11][C:10]([NH:12][C:13]3[O:14][C@:15]4([CH2:23][N:24]=3)[CH:20]3[CH2:21][CH2:22][N:17]([CH2:18][CH2:19]3)[CH2:16]4)=[N:9][CH:8]=2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.C1C=C(Cl)C=C(C(OO)=[O:33])C=1>C1COCC1>[C:1]1([C:7]2[S:11][C:10]([NH:12][C:13]3[O:14][C@:15]4([CH2:23][N:24]=3)[CH:20]3[CH2:19][CH2:18][N+:17]([O-:33])([CH2:22][CH2:21]3)[CH2:16]4)=[N:9][CH:8]=2)[CH:2]=[CH:3][CH:4]=[CH:5][CH:6]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
(R)—N-(5-Phenylthiazol-2-yl)-4H-1′-azaspiro[oxazole-5,3′-bicyclo[2.2.2]octan]-2-amine (0.101 g, 0.297 mmol) was dissolved in THF (15 mL) and treated with m-CPBA (0.061 g, 0.356 mmol) for 30 min. at room temperature. The reaction was concentrated in vacuo to afford the crude product. The crude product was purified by reverse phase HPLC to yield pure fractions. The fractions were concentrated via vacuo and dried in a vac. oven for 18 hours to yield (S)-2-(5-phenylthiazol-2-ylamino)-4H-1′-azaspiro[oxazole-5,3′-bicyclo[2.2.2]octane]1′-oxide (0.03 g, 0.082 mmol, 27.8% yield) as a white powder. 1H NMR (500 MHz, DMSO-d6) δ ppm 7.86-8.12 (m, 1H), 7.64 (br. s., 2H), 7.44 (s, 3H), 4.13-4.31 (m, 3H), 3.97-4.07 (m, 1H), 3.90 (d, J=10.7 Hz, 4H), 3.54-3.74 (m, 1H), 2.28-2.42 (m, 1H), 1.95-2.24 (m, 3H). LC/MS: retention time 1.04 (M+1=357.1).
Workup
- concentrationThe reaction was concentrated in vacuo
- customto afford the crude product
- customThe crude product was purified by reverse phase HPLC
- customto yield pure fractions
- concentrationThe fractions were concentrated via vacuo
- customdried in a vac
Sources & evidence
- ORD record
- ord-9e7b61aa784a4df8b52ee96fc82c9b6c
- Source dataset
- uspto-grants-2013_07
- Patent number
- US08481555B2
Reaction notes
Loading…